Qi et al. observed that PLCG2 was significantly upregulated in the cohort of triple-negative breast cancer patients and had important interactions with the molecular mechanism of triple-negative breast cancer-associated BRCA1 22. This evidence concerns the gene BRCA1 and triple-negative breast carcinoma.